334 related articles for article (PubMed ID: 12198874)
1. [Reflux, smoking, alcohol. Approach to prevention of esophageal carcinoma].
Rotthauwe J; Lingenfelser T; Malfertheiner P
MMW Fortschr Med; 2002 Jul; 144(27-28):26-31. PubMed ID: 12198874
[TBL] [Abstract][Full Text] [Related]
2. Risk of extraesophageal malignancy in patients with adenocarcinoma arising in Barrett's esophagus.
Achkar JP; Post AB; Achkar E; Carey WD
Am J Gastroenterol; 1995 Jan; 90(1):39-43. PubMed ID: 7801946
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention of esophageal squamous cell carcinoma in areas where smoking, alcohol, and betel quid chewing are prevalent.
Chung CS; Lee YC; Wang CP; Ko JY; Wang WL; Wu MS; Wang HP
J Formos Med Assoc; 2010 Jun; 109(6):408-21. PubMed ID: 20610142
[TBL] [Abstract][Full Text] [Related]
4. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
[TBL] [Abstract][Full Text] [Related]
5. Esophageal cancer: epidemiology, pathogenesis and prevention.
Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):517-26. PubMed ID: 18679388
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma of the esophagus: risk factors and prevention.
Heath EI; Limburg PJ; Hawk ET; Forastiere AA
Oncology (Williston Park); 2000 Apr; 14(4):507-14; discussion 518-20, 522-3. PubMed ID: 10826312
[TBL] [Abstract][Full Text] [Related]
7. Should people with Barrett's esophagus, who are at risk for cancer of the esophagus, avoid alcohol?
Enzinger PC
Health News; 2004 Jun; 10(6):16. PubMed ID: 15199910
[No Abstract] [Full Text] [Related]
8. Section I: epidemiological review.
Lukanich JM
Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):158-66. PubMed ID: 12838486
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and pathogenesis of esophageal cancer.
Holmes RS; Vaughan TL
Semin Radiat Oncol; 2007 Jan; 17(1):2-9. PubMed ID: 17185192
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and gene expression in esophageal cancer.
Xu XC
Methods Mol Biol; 2009; 471():335-60. PubMed ID: 19109788
[TBL] [Abstract][Full Text] [Related]
11. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
12. Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus.
Garavello W; Negri E; Talamini R; Levi F; Zambon P; Dal Maso L; Bosetti C; Franceschi S; La Vecchia C
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1390-3. PubMed ID: 15941946
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of esophageal adenocarcinoma.
Pera M; Manterola C; Vidal O; Grande L
J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786
[TBL] [Abstract][Full Text] [Related]
16. Vitamin intake and risk of subtypes of esophageal cancer in Germany.
Bollschweiler E; Wolfgarten E; Nowroth T; Rosendahl U; Mönig SP; Hölscher AH
J Cancer Res Clin Oncol; 2002 Oct; 128(10):575-80. PubMed ID: 12384802
[TBL] [Abstract][Full Text] [Related]
17. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
18. Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?
Gough MD; Ackroyd R; Majeed AW; Bird NC
Am J Gastroenterol; 2005 May; 100(5):1012-8. PubMed ID: 15842572
[TBL] [Abstract][Full Text] [Related]
19. Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.
Kumagai H; Mukaisho K; Sugihara H; Miwa K; Yamamoto G; Hattori T
Carcinogenesis; 2004 May; 25(5):723-7. PubMed ID: 14754873
[TBL] [Abstract][Full Text] [Related]
20. Barrett's Esophagus and esophageal adenocarcinoma.
Bresalier RS
Annu Rev Med; 2009; 60():221-31. PubMed ID: 18783330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
